Differential uptake of DNA-poly(ethylenimine) polyplexes in cells cultured on collagen and fibronectin surfaces

Acta Biomaterialia

Volumn 6, Issue 9, 2010, Pages 3436-3447

  Dhaliwal, Anandika ^a   Maldonado, Maricela ^a   Han, Zenas ^a   Segura, Tatiana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytoskeleton; Endocytosis; Extracellular matrix; Mesenchymal stem cells; Non viral gene delivery

Indexed keywords

COLLAGEN; ENZYME ACTIVITY; FLOWCHARTING; GENE TRANSFER; GENES; MOLECULAR BIOLOGY; STEM CELLS;

COATED SURFACE; COLLAGEN I; CYTOSKELETONS; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX PROTEIN; MESENCHYMAL STEM CELL; NON-VIRAL GENE DELIVERY; NONVIRAL; POLYPLEXES; VIRAL GENES;

CELL CULTURE;

ACTIN; CLATHRIN; COLLAGEN TYPE 1; DNA; FIBRONECTIN; MYOSIN; POLYETHYLENEIMINE; COLLAGEN; IMMOBILIZED PROTEIN;

ANIMAL CELL; ARTICLE; CAVEOLA; CELL CULTURE; CONTROLLED STUDY; ENDOCYTOSIS; EXTRACELLULAR MATRIX; GENE TRANSFER; GENETIC TRANSFECTION; INTERNALIZATION; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PINOCYTOSIS; PRIORITY JOURNAL; TENSION; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; MICROTUBULE; STAINING; SURFACE PROPERTY; TRANSGENE;

ACTINS; ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CLATHRIN; COLLAGEN; DNA; ENDOCYTOSIS; FIBRONECTINS; IMMOBILIZED PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; MICROTUBULES; POLYETHYLENEIMINE; STAINING AND LABELING; SURFACE PROPERTIES; TRANSFECTION; TRANSGENES;

EID: 77956734528     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.03.038     Document Type: Article

References (42)

1. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4(5):346-58.
2. Saul JM, Linnes MP, Ratner BD, Giachelli CM, Pun SH. Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression. Biomaterials 2007;28(31):4705-16.
3. Mairhofer J, Grabherr R. Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA. Mol Biotechnol 2008;39(2):97-104.
4. Bengali Z, Rea JC, Shea LD. Gene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density. J Gene Med 2007;9(8):668-78.
5. Uchimura E, Yamada S, Uebersax L, Yoshikawa T, Matsumoto K, Kishi M, et al. On-chip transfection of PC12 cells based on the rational understanding of the role of ECM molecules: efficient, non-viral transfection of PC12 cells using collagen IV. Neurosci Lett 2005;378(1):40-3.
6. Gao X, Kim KS, Liu D. Nonviral gene delivery: What we know and what is next. AAPS J 2007;9(1):E92-104.
7. Lungwitz U, Breunig M, Blunk T, Gopferich A. Polyethylenimine-based nonviral gene delivery systems. Eur J Pharm Biopharm 2005;60(2):247-66.
8. Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo-polyethylenimine. Proc Natl Acad Sci USA 1995;92(16):7297-301.
9. Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethyleniminemediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005;7(5):657-63.
10. Chen J, Gao X, Hu K, Pang Z, Cai J, Li J, et al. Galactose-poly (ethylene glycol) - polyethylenimine for improved lung gene transfer. Biochem Biophys Res Commun 2008;375(3):378-83.
11. Kircheis R, Wightman L, Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev 2001;53(3):341-58.
12. Mi Bae Y, Choi H, Lee S, Ho Kang S, Tae Kim Y, Nam K, et al. Dexamethasoneconjugated low molecular weight polyethylenimine as a nucleus-targeting lipopolymer gene carrier. Bioconjug Chem 2007;18(6):2029-36.
13. Luo X, Pan S, Feng M, Wen Y, Zhang W. Stability of poly (ethylene glycol)-graftpolyethylenimine copolymer/DNA complexes: influences of PEG molecular weight and PEGylation degree. J Mater Sci 2010;21:597.
14. Kong HJ, Liu J, Riddle K, Matsumoto T, Leach K, Mooney DJ. Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat Mater 2005;4(6):460-4.
15. Kong HJ, Hsiong S, Mooney DJ. Nanoscale cell adhesion ligand presentation regulates nonviral gene delivery and expression. Nano Lett 2007;7(1):161-6.
16. Perlstein I, Connolly JM, Cui X, Song C, Li Q, Jones PL, et al. DNA delivery from an intravascular stent with a denatured collagen-polylactic- polyglycolic acidcontrolled release coating: mechanisms of enhanced transfection. Gene Ther 2003;10(17):1420-8.
17. Yoshikawa T, Uchimura E, Kishi M, Funeriu DP, Miyake M, Miyake J. Transfection microarray of human mesenchymal stem cells and on-chip siRNA gene knockdown. J Control Release 2004;96(2):227-32.
18. Okazaki A, Jo JI, Tabata Y. A reverse transfection technology to genetically engineer adult stem cells. Tissue Eng 2007;13:245.
19. Uchimura E, Yamada S, Uebersax L, Yoshikawa T, Matsumoto K, Kishi M, et al. On-chip transfection of PC12 cells based on the rational understanding of the role of ECM molecules: efficient, non-viral transfection of PC12 cells using collagen IV. Neurosci Lett 2005;378(1):40-3.
20. Kopatz I, Remy JS, Behr JP. A model for non-viral gene delivery through syndecan adhesion molecules and powered by actin. J Gene Med 2004;6(7):769-76.
21. Suh J, Wirtz D, Hanes J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc Natl Acad Sci USA 2003;100(7):3878-82.
22. Kruger-Krasagakes S, Grutzkau A, Krasagakis K, Hoffmann S, Henz BM. Adhesion of human mast cells to extracellular matrix provides a costimulatory signal for cytokine production. Immunology 1999;98(2):253-7.
23. Kumar S, Chanda D, Ponnazhagan S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 2008;15(10):711-5.
24. Wilke M, Fortunati E, van den Broek M, Hoogeveen AT, Scholte BJ. Efficacy of a peptide-based gene delivery system depends on mitotic activity. Gene Ther 1996;3(12):1133-42.
25. Mortimer I, Tam P, MacLachlan I, Graham RW, Saravolac EG, Joshi PB. Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther 1999;6(3):403-11.
26. Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther 2000;7(5):401-7.
27. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 1989;49(18):5111-7.
28. Peroutka SJ, Synder SH. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 1980;137(12):1518-22.
29. Goncalves C, Mennesson E, Fuchs R, Gorvel JP, Midoux P, Pichon C. Macropinocytosis of polyplexes and recycling of plasmid via the clathrindependent pathway impair the transfection efficiency of human hepatocarcinoma cells. Mol Ther 2004;10(2):373-85.
30. Douglas KL, Piccirillo CA, Tabrizian M. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur J Pharm Biopharm 2008;68(3):676-87.
31. von Gersdorff K, Sanders NN, Vandenbroucke R, De Smedt SC, Wagner E, Ogris M. The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type. Mol Ther 2006;14(5):745-53.
32. Brisson M, Tseng WC, Almonte C, Watkins S, Huang L. Subcellular trafficking of the cytoplasmic expression system. Hum Gene Ther 1999;10(16):2601-13.
33. Grosse S, Aron Y, Thevenot G, Monsigny M, Fajac I. Cytoskeletal involvement in the cellular trafficking of plasmid/PEI derivative complexes. J Control Release 2007;122(1):111-7.
34. Lindberg J, Fernandez MA, Ropp JD, Hamm-Alvarez SF. Nocodazole treatment of CV-1 cells enhances nuclear/perinuclear accumulation of lipid-DNA complexes and increases gene expression. Pharm Res 2001;18(2):246-9.
35. Wong AW, Scales SJ, Reilly DE. DNA internalized via caveolae requires microtubule-dependent, Rab7-independent transport to the late endocytic pathway for delivery to the nucleus. J Biol Chem 2007;282(31):22953-63.
36. Li D, Li P, Li G, Wang J, Wang E. The effect of nocodazole on the transfection efficiency of lipid-bilayer coated gold nanoparticles. Biomaterials 2009;30(7):1382-8.
37. Hsu SL, Yu CT, Yin SC, Tang MJ, Tien AC, Wu YM, et al. Caspase 3, periodically expressed and activated at G2/M transition, is required for nocodazoleinduced mitotic checkpoint. Apoptosis 2006;11(5):765-71.
38. Rubtsova SN, Kondratov RV, Kopnin PB, Chumakov PM, Kopnin BP, Vasiliev JM. Disruption of actin microfilaments by cytochalasin D leads to activation of p53. FEBS Lett 1998;430(3):353-7.
39. Bhadriraju K, Yang M, Alom Ruiz S, Pirone D, Tan J, Chen CS. Activation of ROCK by RhoA is regulated by cell adhesion, shape, and cytoskeletal tension. Exp Cell Res 2007;313(16):3616-23.
40. Polte TR, Eichler GS, Wang N, Ingber DE. Extracellular matrix controls myosin light chain phosphorylation and cell contractility through modulation of cell shape and cytoskeletal prestress. Am J Physiol 2004;286(3):C518-28.
41. Thum T, Borlak J. Butanedione monoxime increases the viability and yield of adult cardiomyocytes in primary cultures. Cardiovasc Toxicol 2001;1(1):61-72.
42. Sellin LC, McArdle JJ. Multiple effects of 2, 3-butanedione monoxime. Pharmacol Toxicol 1994;74(6):305-13.